Time to bring drug manufacturing home
Shaving a few dollars off the cost to consumers of some medicines — and yes, padding profits on their sale — have led many U.S. drug companies to rely on overseas manufacturers for the products. Last week, the truth of warnings against such dependence was proven. U.S. public health officials reported a certain drug — which they would not identify — has become scarce in this country because of manufacturing difficulties in China. The trouble is linked to the COVID-19 outbreak that is centered in China and has killed at least 3,000 people there. Food and Drug Administration ...